Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
about
MiR-200c and HuR in ovarian cancerThe microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cellsThe ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?Steroid hormones, steroid receptors, and breast cancer stem cellsThe miR-200 Family: Versatile Players in Epithelial Ovarian CancerMiR-200, a new star miRNA in human cancerThe miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identitymiR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal TransitionThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapyEvaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic PotentialMicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancermiR-200b as a prognostic factor in breast cancer targets multiple members of RAB family3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cellsmiR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expressionDysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer.Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas.Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.Selective release of microRNA species from normal and malignant mammary epithelial cells.miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.The tetraindole SK228 reverses the epithelial-to-mesenchymal transition of breast cancer cells by up-regulating members of the miR-200 family.MicroRNAs: novel players in cancer diagnosis and therapies.Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin.MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation.The role of the miR-200 family in epithelial-mesenchymal transition.RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancerElevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancermiR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cellsSequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells.Minireview: The roles of small RNA pathways in reproductive medicineDirect targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.Targets of miR-200c mediate suppression of cell motility and anoikis resistanceβ-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.miRNAs and estrogen action.MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer
P2860
Q21261258-9B5299BD-8797-4327-9F1E-466F63D00319Q23909716-8C9E944F-D3C5-4D70-B775-723DE4AD921EQ24617121-CEC905DA-05C8-4EA3-8418-BEFDED5D84D6Q26799113-1B777A86-38EE-4502-B8E7-FFD43495AFECQ26799353-DD212364-B099-46B6-A93D-CBAB720DA362Q27004023-66EDA968-4161-4CB0-B02F-204FA97244D9Q27010233-41873E02-B7A8-4699-949A-D70DCE0ADB54Q28071987-DE9104F6-0BEF-4BCE-9A10-44C1761AC86CQ28083742-B1544F75-E330-430F-999C-107B26450E1FQ28084310-5205BD37-FDBE-4EEB-9E2D-6B2EE0E1EA92Q28385520-61057DD6-4B98-4530-A88B-F353583CF257Q28394618-E97F391D-920D-4B05-ADCB-227AB982CAE3Q28485231-66B24B4C-5F82-4AFF-A811-21731CDA4DE7Q28485384-FE6CE8C0-0CDA-47AA-A3B8-C362FCB97953Q30417482-316E4972-B4C1-462C-AEB6-3BDE7616BF7DQ33680107-ADE0031C-AEB6-4CAE-B303-82F426DD9520Q33714207-C4EEDBE3-9D47-422F-8BF5-E2ADD765C64DQ33728084-5973F8EC-EAF8-469E-96C7-45E04D09C7FBQ33804175-39A5CEDE-67ED-4F31-A683-E319CF383A10Q33812557-176D5C5E-A6FF-43E1-81A2-06E47E738115Q33914573-1C4DE64F-C648-4C0D-8A9D-EAAD30223373Q34005444-4FC4E451-4C1D-43C4-BA8B-8FC3DEDF8C55Q34019957-EC0152E9-5ED9-443C-8AC9-3DA92719606AQ34123520-4DEC1992-2EE6-41C2-A628-A96FBEE00D3AQ34298027-199698E5-F012-488C-8CB2-EF797C8B3E17Q34436363-92BFC21A-2752-4BAE-A1E8-F42A133A50DDQ34490836-6222CA94-78AE-49E9-ABCF-57BBAC911D0AQ34526484-241C21EC-F100-417F-AE63-626436D095D7Q34670849-D2FA1440-9A7D-4CA7-97E4-76EED75E73FAQ34693000-543A90D9-6CB0-4074-9894-FAD043E2C311Q35028765-83656049-53A1-452B-BAEE-F736D57C5975Q35135678-FCD03107-4063-42AF-AEDC-0B323937AA8AQ35204515-51D63D29-238C-4831-8045-D0A85C6F01EFQ35545816-5D2950C9-1C10-4F98-B57D-EE4486F383BEQ35559037-7E989B2C-0498-4325-BDA1-D3FB87EC6CA8Q35585837-A93AEB84-1F3B-4DBD-8AAD-B9BD503CAB21Q35632200-4D67669C-4D5C-44C6-90D6-70520C8716EFQ35781414-764BB734-235C-4BBD-BEAB-D0ED5D3BB3ADQ35946984-DC68FFB5-EE1B-4C55-8166-82B9EE5B809FQ36032709-EA7EE634-312B-41B3-BDFE-C9830D185DC7
P2860
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@ast
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@en
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@en-gb
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@nl
type
label
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@ast
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@en
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@en-gb
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@nl
prefLabel
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@ast
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@en
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@en-gb
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@nl
P2093
P2860
P3181
P356
P1433
P1476
Loss of miR-200c: A Marker of ...... in Female Reproductive Cancers
@en
P2093
Dawn R Cochrane
Erin N Howe
Jennifer K Richer
Nicole S Spoelstra
P2860
P304
P3181
P356
10.1155/2010/821717
P407
P577
2010-01-01T00:00:00Z